Condition: Postoperative Pain · Total Shoulder Arthroplasty · Multimodal Analgesia · Sponsor: Heron Therapeutics
This is a Phase 4, randomized, blinded, active-controlled, multicohort study to evaluate HTX-011 compared with bupivacaine HCl in subjects undergoing Total Shoulder Arthroplasty (TSA) (Cohort 1).
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Woodland International Research Group, LLC | Little Rock, Arkansas, United States | — |
| Center for Orthopaedic Reconstruction and Excellence | Jenks, Oklahoma, United States | — |
| First Surgical Hospital | Bellaire, Texas, United States | — |
| Legent Orthopedic Hospital | Carrollton, Texas, United States | — |
| JBR Clinical Research | Salt Lake City, Utah, United States | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06109415